Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation

[1]  Zhi-Sheng Jiang,et al.  Imbalanced cholesterol metabolism in Alzheimer's disease. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Leszek,et al.  Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. , 2016, CNS & neurological disorders drug targets.

[3]  A. Petrov,et al.  Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction , 2016, Acta naturae.

[4]  Junying Gao,et al.  Changes in astrocyte functional markers and β-amyloid metabolism-related proteins in the early stages of hypercholesterolemia , 2016, Neuroscience.

[5]  S. Sil,et al.  Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease , 2016, Behavioural neurology.

[6]  G. Lip,et al.  LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention. , 2015, Clinical science.

[7]  H. Braak,et al.  The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. , 2015, Brain : a journal of neurology.

[8]  W. Griffiths,et al.  The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid , 2015, Steroids.

[9]  W. Griffiths,et al.  Cholesterol metabolites exported from human brain , 2015, Steroids.

[10]  G. Poli,et al.  Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease , 2015, Front. Aging Neurosci..

[11]  P. Clayton,et al.  Quantitative charge-tags for sterol and oxysterol analysis. , 2015, Clinical chemistry.

[12]  Raynoo Thanan,et al.  Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer , 2014, International journal of molecular sciences.

[13]  Y. Surh,et al.  Docosahexaenoic acid inhibits insulin-induced activation of sterol regulatory-element binding protein 1 and cyclooxygenase-2 expression through upregulation of SIRT1 in human colon epithelial cells. , 2014, Biochemical pharmacology.

[14]  T. Hankemeier,et al.  Analysis of oxysterols and vitamin D metabolites in mouse brain and cell line samples by ultra-high-performance liquid chromatography-atmospheric pressure photoionization-mass spectrometry. , 2014, Journal of chromatography. A.

[15]  H. Griffiths,et al.  Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier. , 2014, Biochemical Society transactions.

[16]  R. Cavalli,et al.  Loading into Nanoparticles Improves Quercetin's Efficacy in Preventing Neuroinflammation Induced by Oxysterols , 2014, PloS one.

[17]  M. Vizcaychipi,et al.  Neuroinflammation: The role and consequences , 2014, Neuroscience Research.

[18]  I. Milenkovic,et al.  Distinct Patterns of Sirtuin Expression During Progression of Alzheimer’s Disease , 2014, NeuroMolecular Medicine.

[19]  C. Caltagirone,et al.  Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease , 2013, Neurodegenerative Diseases.

[20]  D. Butterfield,et al.  Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. , 2013, Free radical biology & medicine.

[21]  Nirmal Singh,et al.  Liver X receptors: emerging therapeutic targets for Alzheimer's disease. , 2013, Pharmacological research.

[22]  L. Guarente,et al.  Sirtuin deacetylases in neurodegenerative diseases of aging , 2013, Cell Research.

[23]  A. Dey,et al.  Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s Disease , 2013, PloS one.

[24]  A. Mahadevan,et al.  Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease , 2012, Neurochemical Research.

[25]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[26]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[27]  S. Allan,et al.  Assessing the contribution of inflammation in models of Alzheimer's disease. , 2011, Biochemical Society transactions.

[28]  H. Braak,et al.  Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.

[29]  T. Ohm,et al.  Dietary Cholesterol and Its Effect on Tau Protein: A Study in Apolipoprotein E-Deficient and P301L Human Tau Mice , 2011, Journal of neuropathology and experimental neurology.

[30]  Hyoung-Gon Lee,et al.  The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations , 2011, The Lancet Neurology.

[31]  E. Yaksi,et al.  Electrical Coupling between Olfactory Glomeruli , 2010, Neuron.

[32]  S. Aid,et al.  Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain , 2010, The Pharmacogenomics Journal.

[33]  M. O’Banion,et al.  Neuroinflammatory processes in Alzheimer’s disease , 2010, Journal of Neural Transmission.

[34]  A. A. Farooqui,et al.  Effects of cholesterol oxidation products on exocytosis , 2010, Neuroscience Letters.

[35]  R. Veerhuis,et al.  Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease , 2010, Neurodegenerative Diseases.

[36]  A. A. Farooqui,et al.  Changes in cholesterol biosynthetic and transport pathways after excitotoxicity , 2010, Journal of neurochemistry.

[37]  P. Hof,et al.  Does Alzheimer's disease begin in the brainstem? , 2009, Neuropathology and applied neurobiology.

[38]  L. Polito,et al.  The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide , 2009, Journal of neurochemistry.

[39]  Z. Arvanitakis,et al.  Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase‐1 , 2009, Journal of neurochemistry.

[40]  Steve Meaney,et al.  Oxysterols and neurodegenerative diseases. , 2009, Molecular aspects of medicine.

[41]  Andrew J. Brown,et al.  Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. , 2009, Molecular aspects of medicine.

[42]  M. O’Banion,et al.  Neuroinflammation and Memory: The Role of Prostaglandins , 2009, Molecular Neurobiology.

[43]  E. Candelario-Jalil,et al.  Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia , 2009, Neuroscience.

[44]  D. Bennett,et al.  Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[45]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[46]  P. Moreira,et al.  Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. , 2008, Free radical biology & medicine.

[47]  Domenico Lio,et al.  Inflammation, genes and zinc in Alzheimer's disease , 2008, Brain Research Reviews.

[48]  L. Guarente,et al.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR. , 2007, Molecular cell.

[49]  I. Björkhem,et al.  Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain , 2006, Journal of internal medicine.

[50]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[51]  Jun Wang,et al.  Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.

[52]  A. A. Farooqui,et al.  Lovastatin Modulates Increased Cholesterol and Oxysterol Levels and Has a Neuroprotective Effect on Rat Hippocampal Neurons After Kainate Injury , 2006, Journal of neuropathology and experimental neurology.

[53]  R. Veerhuis,et al.  Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology , 2006, International Journal of Developmental Neuroscience.

[54]  L. Mucke,et al.  SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling* , 2005, Journal of Biological Chemistry.

[55]  C. Eckman,et al.  Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease* , 2004, Journal of Biological Chemistry.

[56]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[57]  E. Feldman,et al.  Neuroinflammation, COX-2, and ALS—a dual role? , 2004, Experimental Neurology.

[58]  J. Seckl,et al.  Dehydroepiandrosterone 7-hydroxylase cyp7b: predominant expression in primate hippocampus and reduced expression in alzheimer's disease☆ , 2003, Neuroscience.

[59]  I. Björkhem,et al.  Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.M200434-JLR200 , 2003, Journal of Lipid Research.

[60]  F. Violi,et al.  Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. , 2003, Analytical biochemistry.

[61]  D. Mann,et al.  Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease , 2002, Neuroscience Letters.

[62]  M. Fiala,et al.  Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier , 2002, European journal of clinical investigation.

[63]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[64]  B. Winblad,et al.  On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells , 2001, Neuroscience Letters.

[65]  F. Aloisi.  Immune function of microglia , 2001, Glia.

[66]  A. Baldwin,et al.  Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. , 2001, The Journal of biological chemistry.

[67]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[68]  D. Dickson,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[69]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[70]  G. V. Van Hoesen,et al.  The selective vulnerability of brainstem nuclei to Alzheimer's disease , 2001, Annals of neurology.

[71]  P. Mcgeer,et al.  Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs , 1999, Brain Research.

[72]  J. Błasiak,et al.  Redox Biology , 2018 .

[73]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[74]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[75]  L. Mucke,et al.  SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. , 2005, The Journal of biological chemistry.

[76]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.